Foreign Corrupt Practices Act (FCPA)

Though the global economy presents expansive opportunities for businesses, global operations and interests create processes which often must be monitored closely for compliance risks.

Our attorneys have advised clients on FCPA matters, including internal and government investigations, in more than 40 countries throughout Africa, Asia, Europe, and North and South America.

We are global anti-corruption and Foreign Corrupt Practices Act (FCPA) counsel to multiple Fortune 500 companies and many other public, private and nonprofit entities across industries including manufacturing, medical devices, healthcare, healthcare information technology, logistics, media, technology and retail.

Our Washington, D.C.-based team members interact regularly with key enforcement agencies, but we provide exceptional cost efficiency because many of our team members are based in the lower-cost Nashville, Tennessee market.

Services include:

  • Representing companies and individuals in anti-corruption investigations and enforcement actions.
  • Conducting international anti-corruption investigations in Africa, Asia, Europe, Mexico, Latin America and the Middle East.
  • Conducting anti-corruption risk assessments.
  • Designing, reviewing and implementing cost-effective anti-corruption compliance policies procedures and internal controls.
  • Supervising international due diligence on third parties.
  • Navigating anti-corruption compliance issues in international mergers, acquisitions, joint ventures, sourcing, contracting, distributing and sales.
  • Assisting clients in drafting anti-corruption contractual language for agents, distributors and other third parties.
  • Conducting anti-corruption training for corporate clients, their employees, agents and third-party business partners.
  • Serving in regulatory monitor roles for some of the most preeminent companies and organizations in the world.

Through our firm’s membership in Lex Mundi and SCG Legal, two of the world’s leading associations of independent law firms, our attorneys have ready access to local counsel and resources in 120 countries.

  • Represented a publicly-traded oilfield services company in an investigation of alleged anti-corruption violations in Africa

    We represented of a publicly-traded oilfield services company in an investigation of alleged anti-corruption and money laundering violations in Africa....
    Read More
    Client Type: Public Company
  • Developed comprehensive sanctions and export compliance policy and procedures for a multinational manufacturing firm

    We developed a comprehensive sanctions and export compliance policy and procedures for a multinational manufacturing firm.
    Read More
  • Conducted a multi-country FCPA and local law investigation in Southeast Asia for a U.S. company 

    We conducted a multi-country FCPA and local law investigation in Southeast Asia for a U.S. company. Internal investigation involved significant...
    Read More
  • Advised a multinational company in review of potential anti-money laundering violations 

    We advised a multinational company in review of potential anti-money laundering violations. 
    Read More
  • Assisted a U.S. financial services firm to understand and meet its anti-bribery due diligence obligations

    We assisted a U.S. financial services firm to understand and meet its anti-bribery due diligence obligations.
    Read More
  • Represented a publicly-traded multinational company in conducting an internal investigation and making voluntary disclosure of FCPA violations to Securities and Exchange Commission (SEC); resulted in formal declination of prosecution by the SEC

    Bass, Berry & Sims attorneys represented a publicly-traded multinational company in an internal investigation into potential FCPA and local law...
    Read More
    Client Type: Public Company
  • Conducted global FCPA compliance risk assessment for a publicly traded international medical device company

    We conducted a global anti-corruption compliance risk assessment for a publicly-traded international medical device company. The results of this assessment,...
    Read More
    Client Type: Public Company
  • Advised a publicly traded U.S. company on anti-corruption due diligence related to the potential acquisition of a U.S. company with an active unresolved DOJ and SEC FCPA investigation

    We advised a publicly traded U.S company on anti-corruption due diligence related to the potential acquisition of U.S. company with...
    Read More
    Client Type: Public Company
  • Represented a Fortune 500 company in the life sciences industry in an investigation by the U.S. Department of Justice and Securities and Exchange Commission

    We represented a Fortune 500 company in the life sciences industry in an investigation by the U.S. Department of Justice...
    Read More
  • Represented a Fortune 500 company in the oil and gas industry in an internal investigation of alleged FCPA and local law violations related to the company’s operations in Nigeria

    We represented a Fortune 500 company in the oil and gas industry in an internal investigation of alleged FCPA and...
    Read More
Samar S. Ali
International Counsel
Richard W. Arnholt
Member
Wallace W. Dietz
Member
John C. Eason
Associate
Lindsey Brown Fetzer
Associate
Mary Beth Fortugno
Member
Kaitlin E. Hazard
Associate
Kate Hunter-Salas
Associate
John E. Kelly
Member
J. Brook Lathram
Member (retired)
Katherine S. Linsey
Associate
Thaddeus R. McBride
Member
Michael J.  Rivera
Member
Kathryn Hannen Walker
Member
Abby Yi
Associate